Literature DB >> 3397527

Distribution and excretion of 74As and 75Se in rats after their simultaneous administration. The effect of arsenic, selenium and combined pretreatment.

M Cikrt1, A Mravcová, I Malátová, V Bencko.   

Abstract

The exposure of man to isolated toxic agent in the environment is rather a rare phenomenon. Therefore the study of a combined action of toxic substances is of increasing importance. The excretion and distribution of 74As (500 micrograms As.kg-1 b.wt.; Na74AsO2) and 75Se (525 micrograms Se.kg-1 b.wt.; Na275SeO3) was studied in rats after their separate and simultaneous i.v. injections. After simultaneous administration urinary as well as biliary excretion of 75Se and urinary excretion of 74As was increased in comparison with that in animals injected the radionuclides separately. Simultaneous administration of 74As and 75Se decreased concentration of 75Se in liver and increased concentration of 74As in kidney. In rats drinking water containing As (III) (0.66 mmol.l-1), Se(IV) (0.13 mmol.l-1) or combination As(III) + Se(IV) (at the same concentrations) for 7 or 28 days was studied the excretion and distribution of 74As and 75Se after their simultaneous i.v. injection (at the same concentrations and labelled compounds as mentioned above). The pretreatment with one element or with the combination of both elements significantly modified the distribution and excretion of subsequently administered 74As and 75Se.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3397527

Source DB:  PubMed          Journal:  J Hyg Epidemiol Microbiol Immunol        ISSN: 0022-1732


  2 in total

1.  Arsenic toxicity in humans: Research problems and prospects.

Authors:  D J Thomas
Journal:  Environ Geochem Health       Date:  1994-12       Impact factor: 4.609

2.  Study of distribution and interaction of arsenic and selenium in rat thyroid.

Authors:  E Glattre; A Mravcova; J Lener; M Vobecky; E Egertova; M Mysliveckova
Journal:  Biol Trace Elem Res       Date:  1995 Aug-Sep       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.